153 related articles for article (PubMed ID: 28786105)
61. Chemoprevention strategies in lung carcinogenesis.
Lippman SM; Benner SE; Hong WK
Chest; 1993 Jan; 103(1 Suppl):15S-19S. PubMed ID: 8416769
[TBL] [Abstract][Full Text] [Related]
62. Chemoprevention with interferon alfa and 13-cis retinoic acid in the adjunctive treatment of head and neck cancer.
Büntzel J; Küttner K
Auris Nasus Larynx; 1998 Dec; 25(4):413-8. PubMed ID: 9853666
[TBL] [Abstract][Full Text] [Related]
63. The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer.
Bongers V; Braakhuis BJ; Tobi H; Lubsen H; Snow GB
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):595-8. PubMed ID: 8824360
[TBL] [Abstract][Full Text] [Related]
64. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
65. Treatment Modality and Second Primary Tumors of the Head and Neck.
Ben Arie G; Shafat T; Belochitski O; El-Saied S; Joshua BZ
ORL J Otorhinolaryngol Relat Spec; 2021; 83(6):420-427. PubMed ID: 34587611
[TBL] [Abstract][Full Text] [Related]
66. PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck.
Wirth LJ; Dakhil S; Kornek G; Axelrod R; Adkins D; Pant S; O'Brien P; Debruyne PR; Oliner KS; Dong J; Murugappan S
Oral Oncol; 2016 Oct; 61():31-40. PubMed ID: 27688102
[TBL] [Abstract][Full Text] [Related]
67. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
68. Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
Harrington K; Temam S; Mehanna H; D'Cruz A; Jain M; D'Onofrio I; Manikhas G; Horvath Z; Sun Y; Dietzsch S; Dubinsky P; Holeckova P; El-Hariry I; Franklin N; Biswas-Baldwin N; Legenne P; Wissel P; Netherway T; Farrell J; Ellis C; Wang-Silvanto J; Amonkar M; Ahmed N; Santillana S; Bourhis J
J Clin Oncol; 2015 Dec; 33(35):4202-9. PubMed ID: 26527790
[TBL] [Abstract][Full Text] [Related]
69. Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer.
Keller SM; Vangel MG; Wagner H; Schiller J; Herskovic A; Komaki R; Gray R; Marks RS; Perry MC; Livingston RB; Johnson DH;
Lung Cancer; 2003 Oct; 42(1):79-86. PubMed ID: 14512191
[TBL] [Abstract][Full Text] [Related]
70. Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
Browman GP; Goodyear MD; Levine MN; Russell R; Archibald SD; Young JE
J Clin Oncol; 1990 Feb; 8(2):203-8. PubMed ID: 2405105
[TBL] [Abstract][Full Text] [Related]
71. [Second primary tumors in patients with carcinoma of the head and neck].
Herranz González-Botas J; Sarandeses García A; Martínez Vidal J; Vázquez Barro C; López Amado M
Acta Otorrinolaringol Esp; 2000 Mar; 51(2):149-53. PubMed ID: 10804117
[TBL] [Abstract][Full Text] [Related]
72. DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.
Overgaard J; Hoff CM; Hansen HS; Specht L; Overgaard M; Lassen P; Andersen E; Johansen J; Andersen LJ; Evensen JF; Alsner J; Grau C
Radiother Oncol; 2018 Apr; 127(1):12-19. PubMed ID: 29523409
[TBL] [Abstract][Full Text] [Related]
73. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
74. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
[TBL] [Abstract][Full Text] [Related]
75. Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.
Nourissat A; Bairati I; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B; Meyer F
Support Care Cancer; 2012 Mar; 20(3):591-9. PubMed ID: 21424341
[TBL] [Abstract][Full Text] [Related]
76. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial.
Corvò R; Benasso M; Sanguineti G; Lionetto R; Bacigalupo A; Margarino G; Pallestrini E; Merlano M; Vitale V; Rosso R
Cancer; 2001 Dec; 92(11):2856-67. PubMed ID: 11753959
[TBL] [Abstract][Full Text] [Related]
77. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
[TBL] [Abstract][Full Text] [Related]
78. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases.
Rennemo E; Zätterström U; Boysen M
Laryngoscope; 2008 Aug; 118(8):1350-6. PubMed ID: 18496157
[TBL] [Abstract][Full Text] [Related]
79. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
80. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
